Non-invasive grading of oligodendrogliomas: Correlations between in vivo metabolic pattern and histopathology

European Journal of Nuclear Medicine

Volumn 27, Issue 7, 2000, Pages 778-787

  Derlon, J M ^a,b   Chapon, F ^a   Noel M H ^b   Khouri, S ^a   Benali, K ^a,b   Petit Taboue M C ^b   Houtteville, J P ^a   Chajari, M H ^b   Bouvard, G ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b GIP CYCERON   (France)

Author keywords

Brain tumour; Oligodendroglioma; Positron emission tomography

Indexed keywords

AMINO ACID; FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; TRACER;

ADULT; AMINO ACID METABOLISM; ARTICLE; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GLYCOLYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; TUMOR DIAGNOSIS;

EID: 0033945812     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000260     Document Type: Article

References (37)

1. 1. Bailey P, Cushing H. A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis. Philadelphia: Lippincott, 1926.
2. 11C-L-methyl methionine. Neurosurgery 1997; 40: 276-288.
3. 3. Kleihues P, Cavenee WK. Pathology and genetics. In: Kleihues P, Cavenee W, eds. Tumors of the nervous system. Lyon: International Agency for Research on Cancer, 1997.
4. 4. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP. Oligodendrogliomas. Part I. Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 1997; 34: 37-59.
5. 5. Daumas-Duport C, Tucker ML, Kolles H, Cervera P, Beuvon F, Varlet P, Udo N, Koziak M, Chodkiewics JP. Oligodendrogliomas. Part II. A new grading system based on morphological and imaging criteria. J Neurooncol 1997; 34: 61-68.
6. 6. Fox PT, Perlmutter JS, Raichle ME. A stereotactic method of anatomical localization for positron emission tomography. J Comput Assist Tomogr 1985; 9: 141-153.
7. 11C]methionine using whole-body positron emission tomography. Eur J Nucl Med 1998; 25: 629-633.
8. 8. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980; 238: E69-E82.
9. 9. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro2deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371-388.
10. 10. Kernohan JW, Sayre GP. Tumors of the central nervous system. Atlas of tumor pathology. Washington : Armed Forces Institute, 1952, Fascicle 35.
11. 11. Smith MT, Ludwig CL, Godfrey AD, Armbrustmacher VW. Grading of oligodendrogliomas.Cancer 1983; 52: 2107-2114.
12. 12. Bruner JM. Oligodendrgliomas: diagnosis and prognosis. Semin Diag Pathol 1987; 4: 251-261.
13. 13. Ludwig CL, Smith MT, Godfrey AD, Armbrustmacher VW. A clinicopathological study of 323 patients with oligodendrogliomas. Ann Neurol 1986; 19: 15-21.
14. 14. Mork SJ, Halvorsen TB, Lindegaard KF, Eide GE. Oligodendroglioma. Histologic evaluation and prognosis. J Neurol Exp Neurol 1986; 45: 65-78.
15. 15. Cairncross JG, Macdonald DR, Ramsay DA. Aggressive oligodendroglioma: a chemosensitive tumor. Neurosurgery 1992; 31: 78-82.
16. 16. Paleologos NA, Cairncross JG. Treatment of oligodendroglioma : an update. Neurooncology 1999; 1: 61-68.
17. 17. Berger MS, Kincaid J, Ojemann GA. Brain mapping techniques to maximize resection, safety, and seizure control in children with brain tumors. Neurosurgery 1989; 25: 786-792.
18. 18. Jack CR, Thompson RM, Kim Butts R, Sharbrough FW, Kelly PJ, Hanson DP, Riederer SF, Ehman RL, Hangiandreou NJ, Cascino GD. Sensory motor cortex; correlation of presurgical mapping with functional MR imaging and invasive cortical mapping. Radiology 1994; 190: 85-92.
19. 19. Apuzzo MLJ. Evolving dimensions at the frontiers of human cerebral surgery. In: Apuzzo MLJ, ed. Benign cerebral glioma. Neurosurgical topics. American Association of Neurological Surgeons; 1995: 1-12.
20. 20. Ganslandt O, Steinmeier R, Kober H, Vieth J, Kassubek J, Romstöck J, Strauss C, Fahlbusch R. Magnetic source imaging combined with image-guided frameless stereotaxy: a new method in surgery around the motor strip. Neursurgery 1997; 41: 621-628.
21. 18F]fluorodeoxy-glucose and positron emission tomography. Neurology 1982; 32: 1323-1329.
22. 18F]fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1986; 22: 360-371.
23. 23. Patronas NJ, Di Chiro G, Kufta G, Bairamian D, Kornblith PL, Simon R, Larson SM. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurgery 1985; 62: 816-822.
24. 24. Alavi JB, Alavi A, Chawluc J, Kushner M, Powe J, Kickey W, Reivich M. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 1988; 62: 1074-1078.
25. 18F fluorodeoxyglucose. J Neurooncology 1991; 10: 85-91.
26. 26. Schifter T, Hoffman JM, Hanson MW, Boyko OB, Beam C, Paine S, Schuld SG, Burger PC, Coleman RE. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomogr 1993; 17: 509-516.
27. 27. Francavilla TL, Miletich RS, Di Chiro G, Patronas NJ, Rizzoli HV, Wright DC. Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. Neurosurgery 1989; 24: 1-5.
28. 11C]L-methionine uptake in gliomas. Neurosurgery 1989; 25: 720-728.
29. 68Ga) EDTA in supratentorial tumors. J Comput Assist Tomogr 1985; 9: 683-689.
30. 11C-labeled amino acids. J Comput Assist Tomogr 1982; 6: 544-550.
31. 18F) fluorotyrosine. J Nucl Med 1991; 32: 1338-1346.
32. 32. Kameyama M, Tsurumi Y, Shirane R, Katakura R, Suzuki J, Itoh M, Fukuda K, Matsuzawa T, Watanuki S, Ido T. Multiparametric analysis of brain tumor with PET. J Cereb Blood Flow Metab 1987; 7 (S1): S466.
33. 33. Meyer GJ, Schober O, Gaab MR, Kietz H, Hundeshagen H. Multi-parameter studies in brain tumors. In: Beckers C, Goffinet A. Bol K, eds. PET in clinical research and clinical diagnosis., Dordrecht: Kluwer Academic; 1989: 229-248.
34. 34. Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, Luxen A, Reznik M. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon 11-methionine. J Nucl Med 1998: 39; 778-785.
35. 11C-methionine PET for differential diagnosis of low-grade. Neurology 1998; 50: 1316-1322.
36. 36. Kikuchi K, Kowada M, Mineura K, Uemura K. Primary oligodendroglioma of the lateral ventricle with computed tomographic and positron tomographic evaluation. Surg Neurol 1985; 23: 483-488.
37. 11C-L-methionine and PET: a case report. Eur Neurol 1993; 33: 248-251.